We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OGD Aims to Finish Up Work on Scientific Priorities From Prior Years
OGD Aims to Finish Up Work on Scientific Priorities From Prior Years
The FDA’s Office of Generic Drugs is going to focus on meeting its scientific priorities from previous years, instead of setting out to accomplish new projects for this fiscal year – the final year of the five-year authorization for GDUFA.